FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:1503-1516 April 12, 2007 Number 15 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Supplementary Material Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events.

Methods We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6).

Results There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33).

Conclusions As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov] .)

Source Information

Affiliations for all authors are listed in the Appendix.

This article (10.1056/NEJMoa070829) was published at www.nejm.org on March 26, 2007.

Address reprint requests to Dr. Boden at the Division of Cardiology, Buffalo General Hospital, 100 High St., Buffalo, NY 14203, or at wboden{at}kaleidahealth.org.

Full Text of this Article

This article has been cited by other articles:

• Saito, M, Okayama, H, Nishimura, K, Ogimoto, A, Ohtsuka, T, Inoue, K, Hiasa, G, Sumimoto, T, Higaki, J (2008). Possible link between large artery stiffness and coronary flow velocity reserve. Heart 94: e20-e20 [Abstract] [Full Text]  
• Vrints, C. J. M. (2008). Acute coronary syndrome in the elderly. Eur Heart J 29: 1213-1214 [Full Text]  
• Ketterer, M. W., Knysz, W., Keteyian, S.J., Schairer, J., Jafri, S., Alam, M., Farha, A.J., Deveshwar, S. (2008). Cardiovascular Symptoms in Coronary-Artery Disease Patients Are Strongly Correlated With Emotional Distress. Psychosomatics 49: 230-234 [Abstract] [Full Text]  
• Hannan, E. L., Racz, M., Holmes, D. R., Walford, G., Sharma, S., Katz, S., Jones, R. H., King, S. B. III (2008). Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents. Circulation 117: 2071-2078 [Abstract] [Full Text]  
• Holmvang, L., Mickley, H. (2008). Review: Gender differences following percutaneous coronary intervention. Therapeutic Advances in Cardiovascular Disease 2: 109-113 [Abstract]  
• Boden, W. E., Maron, D. J. (2008). Reducing Post-Myocardial Infarction Mortality in the Elderly: The Power and Promise of Secondary Prevention. J Am Coll Cardiol 51: 1255-1257 [Full Text]  
• Bittner, V. (2008). Angina Pectoris: Reversal of the Gender Gap. Circulation 117: 1505-1507 [Full Text]  
• DeMaria, A. N. (2008). Clinical trials and clinical judgment.. J Am Coll Cardiol 51: 1120-1122 [Full Text]  
• Shaw, L. J., Berman, D. S., Maron, D. J., Mancini, G. B. J., Hayes, S. W., Hartigan, P. M., Weintraub, W. S., O'Rourke, R. A., Dada, M., Spertus, J. A., Chaitman, B. R., Friedman, J., Slomka, P., Heller, G. V., Germano, G., Gosselin, G., Berger, P., Kostuk, W. J., Schwartz, R. G., Knudtson, M., Veledar, E., Bates, E. R., McCallister, B., Teo, K. K., Boden, W. E., for the COURAGE Investigators, (2008). Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation 117: 1283-1291 [Abstract] [Full Text]  
• Taggart, D. P., Kaul, S., Boden, W. E., Ferguson, T. B. Jr, Guyton, R. A., Mack, M. J., Sergeant, P. T., Shemin, R. J., Smith, P. K., Yusuf, S. (2008). Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery.. J Am Coll Cardiol 51: 885-892 [Abstract] [Full Text]  
• Sanz, J., Moreno, P. R., Fuster, V. (2008). The year in atherothrombosis.. J Am Coll Cardiol 51: 944-955 [Full Text]  
• Min, J. K., Hofstra, L., Gurudevan, S. V., Cerqueira, M. D. (2008). Imaging Highlights of the American Heart Association 2007 Scientific Sessions. J Am Coll Cardiol Img 1: 252-262 [Full Text]  
• Ryding, A D S, Banning, A P (2008). Which patients receiving warfarin can be treated safely with a drug-eluting stent?. Heart 94: 275-277 [Full Text]  
• Kirtane, A. J., Ellis, S. G., Dawkins, K. D., Colombo, A., Grube, E., Popma, J. J., Fahy, M., Leon, M. B., Moses, J. W., Mehran, R., Stone, G. W. (2008). Paclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus Pooled Analysis From 5 Randomized Trials.. J Am Coll Cardiol 51: 708-715 [Abstract] [Full Text]  
• Jeremias, A., Kirtane, A. (2008). Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention. ANN INTERN MED 148: 234-238 [Abstract] [Full Text]  
• Chester, M. (2008). Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart 94: 229-229 [Full Text]  
• Holmes, D. R. Jr, Gersh, B. J., Whitlow, P., King, S. B. III, Dove, J. T. (2008). Percutaneous Coronary Intervention for Chronic Stable Angina: A Reassessment. J Am Coll Cardiol Intv 1: 34-43 [Abstract] [Full Text]  
• Cheng, A. S.H., Selvanayagam, J. B., Jerosch-Herold, M., van Gaal, W. J., Karamitsos, T. D., Neubauer, S., Banning, A. P. (2008). Percutaneous Treatment of Chronic Total Coronary Occlusions Improves Regional Hyperemic Myocardial Blood Flow and Contractility: Insights From Quantitative Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol Intv 1: 44-53 [Abstract] [Full Text]  
• American College of Cardiology/American Heart Asso, , 2007 Writing Group to Review New Evidence and Upda, , King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. J Am Coll Cardiol 51: 172-209 [Full Text]  
• King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, , Smith, S. C. Jr, Feldman, T. E., Hirshfeld, J. W. Jr, Jacobs, A. K., Kern, M. J., King, S. B. III, Morrison, D. A., O'Neill, W. W., Schaff, H. V., Whitlow, P. L., Williams, D. O., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 117: 261-295 [Full Text]  
• Chester, M. R (2008). Consider palliative coronary intervention. BMJ 336: 59-59 [Full Text]  
• Liu, B., Han, M., Wen, J.-K. (2008). Acetylbritannilactone Inhibits Neointimal Hyperplasia after Balloon Injury of Rat Artery by Suppressing Nuclear Factor-{kappa}B Activation. J. Pharmacol. Exp. Ther. 324: 292-298 [Abstract] [Full Text]  
• American Diabetes Association, (2008). Standards of Medical Care in Diabetes--2008. Diabetes Care 31: S12-S54 [Full Text]  
• Mehra, M. R, Uber, P. A, Ventura, H. O (2007). Death messengers. BMJ 335: 1296-1297 [Full Text]  
• Cheng, S., Jarcho, J. (2007). Management of Stable Coronary Disease -- Polling Results. NEJM 357: e28-e28 [Full Text]  
• Gibbons, R. J., Fihn, S. D. (2007). Coronary Revascularization: New Evidence, New Challenges. ANN INTERN MED 147: 732-734 [Full Text]  
• Gould, K. L. (2007). Not All Randomized Trials Are Equal. J Am Coll Cardiol 50: 2013-2015 [Full Text]  
• Lamas, G. A, Hochman, J. S (2007). Where does the Occluded Artery Trial leave the late open artery hypothesis?. Heart 93: 1319-1321 [Abstract] [Full Text]  
• Seneviratne, S. K, Bamberg, F., Hoffmann, U. (2007). CT angiography: front line for acute coronary syndromes now?. Heart 93: 1325-1326 [Abstract] [Full Text]  
• Karthikeyan, G., Xavier, D., Prabhakaran, D., Pais, P. (2007). Perspectives on the management of coronary artery disease in India. Heart 93: 1334-1338 [Abstract] [Full Text]  
• Shavelle, D. M (2007). Long term medical treatment of stable coronary disease. Heart 93: 1473-1477 [Full Text]  
• Wackers, F. J. Th., Chyun, D. A., Young, L. H., Heller, G. V., Iskandrian, A. E., Davey, J. A., Barrett, E. J., Taillefer, R., Wittlin, S. D., Filipchuk, N., Ratner, R. E., Inzucchi, S. E., for the Detection of Ischemia in Asymptomatic Diab, (2007). Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study. Diabetes Care 30: 2892-2898 [Abstract] [Full Text]  
• Diamond, G. A., Kaul, S. (2007). COURAGE Under Fire: On the Management of Stable Coronary Disease. J Am Coll Cardiol 50: 1604-1609 [Abstract] [Full Text]  
• Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., Barrett, E. J. (2007). Screening for Coronary Artery Disease in Patients With Diabetes. Diabetes Care 30: 2729-2736 [Abstract] [Full Text]  
• Mark, D. B (2007). Percutaneous coronary revascularisation: is it ever worth what it costs?. Heart 93: 1161-1163 [Full Text]  
• Gershlick, T., Thomas, M. (2007). PCI or CABG: which patients and at what cost?. Heart 93: 1188-1190 [Full Text]  
• Mahmarian, J. J. (2007). Computed Tomography Coronary Angiography as an Anatomic Basis for Risk Stratification: Deja Vu or Something New?. J Am Coll Cardiol 50: 1171-1173 [Full Text]  
• Erne, P., Schoenenberger, A. W., Zuber, M., Burckhardt, D., Kiowski, W., Dubach, P., Resink, T., Pfisterer, M. (2007). Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study. Eur Heart J 28: 2110-2117 [Abstract] [Full Text]  
• Steg, P. G. (2007). Overview of large morbidity/mortality trials with ivabradine: focus on the BEAUTIfUL study. Eur Heart J Suppl 9: F15-F19 [Abstract] [Full Text]  
• Bobba, R. K., Bollu, M., Arsura, E. L. (2007). Off-Label Use of Drug-Eluting Stents. JAMA 298: 859-859 [Full Text]  
• Kalay, N., Ozdogru, I. (2007). Percutaneous Coronary Interventions for Silent Ischemia After Myocardial Infarction. JAMA 298: 860-860 [Full Text]  
• Beohar, N., Davidson, C. J., Kip, K. E., Vlachos, H. A., Williams, D. O. (2007). Off-Label Use of Drug-Eluting Stents Reply. JAMA 298: 859-860 [Full Text]  
• Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50: e1-e157 [Full Text]  
• Moscucci, M. (2007). Behavioral Factors, Bias, and Practice Guidelines in the Decision to Use Percutaneous Coronary Interventions for Stable Coronary Artery Disease. Arch Intern Med 167: 1573-1575 [Full Text]  
• Spencer, F. A., Steg, P. G. (2007). Major bleeding after PCI. Where is our crystal ball?. Eur Heart J 28: 1917-1919 [Full Text]  
• Pitt, B. (2007). Percutaneous coronary intervention plus optimal medical therapy was not more effective than medical therapy alone in stable CAD. Evid. Based Med. 12: 107-107 [Full Text]  
• Gerber, T. C., Kantor, B., Chareonthaitawee, P. (2007). Coronary computed tomographic angiography and exercise electrocardiography: a great match or unequal partners?. Eur Heart J 28: 1787-1789 [Full Text]  
• Lindsay, A. (2007). JournalScan. Heart 93: 1008-1010 [Full Text]  
• Katritsis, D. G., Ioannidis, J. P.A., Wharton, T. P. Jr., Umans, V. A., Peels, H. O., Shah, A. P., Shavelle, D. M., French, W. J., De Servi, S., Kiat, H., Nagajothi, N., Velazquez-Cecena, J.-L. E., Khosla, S., Mak, K.-H., Boden, W. E., Teo, K. K., Weintraub, W. S., the COURAGE Trial Investigators, (2007). PCI for Stable Coronary Disease. NEJM 357: 414-418 [Full Text]  
• Kaul, S., Shah, P. K., Diamond, G. A. (2007). As Time Goes By: Current Status and Future Directions in the Controversy Over Stenting. J Am Coll Cardiol 50: 128-137 [Abstract] [Full Text]  
• Granada, J. F., Raizner, A. E., Kaluza, G. L. (2007). Animal Models and Virtual Histology. Arterioscler. Thromb. Vasc. Bio. 27: 1667-1668 [Full Text]  
• Erne, P., Schoenenberger, A. W., Burckhardt, D., Zuber, M., Kiowski, W., Buser, P. T., Dubach, P., Resink, T. J., Pfisterer, M. (2007). Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial. JAMA 297: 1985-1991 [Abstract] [Full Text]  
• Newby, L. K., Peterson, E. D. (2007). Does Ranolazine Have a Place in the Treatment of Acute Coronary Syndromes?. JAMA 297: 1823-1825 [Full Text]  
• Hochman, J. S., Steg, P. G. (2007). Does Preventive PCI Work?. NEJM 356: 1572-1574 [Full Text]  
• (2007). Does PCI Improve Survival and Prevent MI in Stable CAD?. Journal Watch Cardiology 2007: 1-1 [Full Text]